Physician profile
Steven A Mann
NPI 1326420761
$495.05
in general payments reported to CMS, 2019-2025
8 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Clinical Pathology/Laboratory Medicine provider received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $123 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $123.48 | 2023 | Virtuoso System For Ihc, Benchmark Special Stains Wash II |
| Astrazeneca Pharmaceuticals LP | $116.64 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.48 | 2025 | Entyvio, Eohilia |
| Astellas Pharma US INC | $46.74 | 2025 | Vyloy |
| Daiichi Sankyo INC. | $41.00 | 2025 | |
| Ardelyx, INC. | $30.96 | 2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $22.97 | 2025 | Dupixent |
| Lilly USA, LLC | $15.78 | 2025 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.